# To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.

> **NCT03105297** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 91 (actual)

## Conditions studied

- Sleep Disordered Breathing
- Congestion, Nasal

## Interventions

- **DEVICE:** Prototype nasal dilator strip
- **OTHER:** No strip

## Key facts

- **NCT ID:** NCT03105297
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-25
- **Primary completion:** 2010-08-10
- **Final completion:** 2010-08-10
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2019-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03105297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03105297, "To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03105297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*